Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study
Overview of attention for article published in Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease, September 2016
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
Good Attention Score compared to outputs of the same age (78th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)
Readers on
- mendeley
- 166 Mendeley